Transforming the treatment of preeclampsia by harnessing Nobel prize-winning science.
Comanche is a biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia. Our purpose is to lower the risks of pregnancy and prematurity worldwide by safely sustaining pregnancy. We envision a world where all pregnant women have access to safe and effective therapies that are evidence-based, cost-effective and sustainable.
Learn About Our WorkMeet Our Team
Read our latest news
Learn More
Contact Us
50 Beharrell St, Unit B
Concord, MA 01742